Showing results (501-510 of 642) with videos related to
Sort By:
Pageof 65
Epilepsy & Behavior : E&B|December 10, 2017
Cognitive impairment and quality of life of people with epilepsy and neurocysticercosis in ZambiaAnne L Nau, Kabemba E Mwape, Jasmin Wiefek, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 28, 2026
The role of brain health and resilience in reshaping trajectories of late-life neuropsychiatric disordersHelen Lavretsky, Sahib Khalsa, Hanadi Ajam Oughli, et al.Journal of the Neurological Sciences|August 20, 2018
Where there is no brain imaging: Safety and diagnostic value of lumbar puncture in patients with neurological disorders in a rural hospital of Central AfricaDeby Mukendi, Jean-Roger Lilo Kalo, Tharcisse Kayembe, et al.Tropical Medicine & International Health : TM & IH|July 6, 2021
Neurocysticercosis and HIV/AIDS co-infection: A scoping reviewPaul D Jewell, Annette Abraham, Veronika Schmidt, et al.Biomarkers in Medicine|January 13, 2018
Syndecan-1 as a biomarker for sepsis survival after major abdominal surgeryMaximilian S Holzmann, Martin S Winkler, Mike S Strunden, et al.Mbio|April 25, 2022
Evidence for an ACE2-Independent Entry Pathway That Can Protect from Neutralization by an Antibody Used for COVID-19 TherapyMarkus Hoffmann, Anzhalika Sidarovich, Prerna Arora, et al.BMC Infectious Diseases|April 18, 2021
High frequency of Taenia solium antigen positivity in patients admitted for neurological disorders in the Rural Hospital of Mosango, Democratic Republic of CongoDeby Mukendi, Jean-Roger Lilo Kalo, Pascal Lutumba, et al.Infectious Diseases of Poverty|September 27, 2018
Burden of onchocerciasis-associated epilepsy: first estimates and research prioritiesNatalie V S Vinkeles Melchers, Sarah Mollenkopf, Robert Colebunders, et al.Cell Reports|April 27, 2022
SARS-CoV-2 variants C.1.2 and B.1.621 (Mu) partially evade neutralization by antibodies elicited upon infection or vaccinationPrerna Arora, Amy Kempf, Inga Nehlmeier, et al.Scientific Reports|October 31, 2019
Potential usefulness of C-reactive protein and procalcitonin determination in patients admitted for neurological disorders in rural Democratic Republic of CongoEmmanuel Bottieau, Deby Mukendi, Jean-Roger Lilo Kalo, et al.Pageof 65